Latest News
Tempest Therapeutics, Inc.
- Tempest Therapeutics, Inc. Estimates – LS:A41556
- Why Is Tempest (NASDAQ:TPST) Up 12.90% Premarket?
- Tempest Therapeutics adjourns special meeting, sets reconvened date for November
- Form 8K Tempest Therapeutics Inc For: 20 October By Investing.com
- Tempest Therapeutics appoints John Frederick to Board as Class III director
- Form PRE 14A Tempest Therapeutics For: 17 October By Investing.com
- Tempest Therapeutics (TPST) Slips 6.77% to $0.64 as Shares Test Key Support - Volume Breadth
- Tempest Therapeutics, Inc. Announces Appointment of John W. Frederick as Director
- Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
- With $0 left to sell, Tempest Therapeutics (TPST) reports a warrant offering.
Headlines from the last 30 days, linking to the original publishers. See all market news →